VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1673730
Sex: F
Age:
State: TX

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Vision went suddenly blurry; Moderate headache; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0151) via an unspecified route of administration in the left arm on 15Apr2021 at 09:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Concomitant medications included paracetamol (TYLENOL), colecalciferol (VITAMIN D3), curcuma longa rhizome (TURMERIC), unspecified multi-vit and probiotic; all taken for unknown indications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 15Apr2021 at 22:00, approximately 14 hours after receiving the first vaccine, the patient's vision went suddenly blurry for about 20 minutes. On 15Apr2021, the patient also had a moderate headache that developed about 1-2 hours prior to her vision going blurry. She had never experienced blurry vision before, so this was definitely not ordinary for her. The patient's vision returned to normal, and the following morning, her headache had subsided. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events moderate headache was resolved on 16Apr2021 and the event vision went suddenly blurry was resolved on 15Apr2021 at 22:20. No follow-up attempts are needed. No further information is expected.

Other Meds: TYLENOL; VITAMIN D3; TURMERIC [CURCUMA LONGA RHIZOME]

Current Illness:

ID: 1673731
Sex: F
Age:
State: MA

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Injection site soreness; Headache; General fatigue; This is a spontaneous report from a non-contactable consumer. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 17Apr2021 at 10:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 27Mar2021 at 10:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021, the patient experienced injection site soreness, headache and general fatigue. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events injection site soreness, headache and general fatigue was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 1673732
Sex: F
Age:
State: CA

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Headache; Body aches; Tiredness; Sore entire arm- still sore; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENO158) via an unspecified route of administration in the left arm on 16Apr2021 at 14:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any medication within two weeks of COVID-19 vaccine. On 16Apr2021 at 14:30, the patient experienced headache, body aches, tiredness, sore entire arm- still sore. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, body aches, tiredness was recovered with sequelae at the time of this report. While the clinical outcome of the event sore entire arm was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness: Penicillin allergy

ID: 1673733
Sex: F
Age:
State: NJ

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Fever; The left side of my face was swollen; I had a uncontrolable bloody nose; This is a spontaneous report from a contactable consumer, the patient. A non-pregnant female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 17Apr2021 at 09:45 as a single dose for COVID-19 immunisation. Medical history included fruit allergy to blueberries. Concomitant medications included zolpidem tartrate (AMBIEN) and amfetamine aspartate; amfetamine sulfate; dexamfetamine saccharate; dexamfetamine sulfate (ADDERALL) for an unknown indication from an unknown date. The patient previously took acetylsalicylic acid (ASPIRIN) for an unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 08:00, the patient experienced fever, the left side of the face was swollen, and had an uncontrollable bloody nose. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events (unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, the left side of her face was swollen and uncontrollable bloody nose were recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: AMBIEN; ADDERALL

Current Illness:

ID: 1673734
Sex: F
Age:
State: MI

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Nausea; Dry heaving; Head fog; Really bad corse tremors; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 15Apr2021 at 13:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included crohn's disease, gastro-oesophageal reflux disease (gerd), heart block (reported as level one heart blockage), cardiac valve leak (reported as leak in valve of heart), heart murmur, fully hysterectomy (reported as fully hysterectomy), tonsillectomy, adenoidectomy (reported as , tonsils and adenoids removed). The patient had seasonal allergy and contrast media allergy. Concomitant medications taken within two weeks of vaccination included acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN), vitamin d nos (MANUFACTURER UNKNOWN), ondansetron (ZOFRAN) and estradiol (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 13:00, the patient experienced nausea, dry heaving, head fog, really bad corse tremors. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of nausea, dry heaving, head fog, really bad corse tremors and included treatment with benadryl, pepcid, zofran. The clinical outcome of the events nausea, dry heaving, head fog, really bad corse tremors was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]; VITAMIN D NOS; ZOFRAN [ONDANSETRON]; ESTRADIOL

Current Illness:

ID: 1673735
Sex: F
Age:
State: FL

Vax Date: 03/25/2021
Onset Date: 03/31/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Rash on the arm of the injection; minimal itching; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6200) via an unspecified route of administration in the right arm on 25Mar2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included cholesterol, irritable bowel syndrome, gastroparesis and essential tremor. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included propranolol hydrochloride (PROPRANOL) and atorvastatin (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. The patient previously took bupropion hydrochloride (WELLBUTRIN) from an unknown date for an unspecified indication and experienced drug allergy. On 31Mar2021, the patient experienced COVID arm; about a week after getting the vaccine, got a rash on the arm of the injection, it cleared up on its own within a few days without incident, and with minimal itching. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events COVID arm; about a week after getting the vaccine, got a rash on the arm of the injection, and with minimal itching recovered on an unknown date 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: PROPRANOL; ATORVASTATIN

Current Illness:

ID: 1673736
Sex: F
Age:
State: MO

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Shingles diagnosis due to Pfzier shot lowering immune system; Shingles diagnosis due to Pfzier shot lowering immune system; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 11:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications within two weeks of vaccination. The patient previously received acetylsalicylic acid (ASPIRIN) on an unknown date, for unknown indication and experienced upset stomach. The patient did not receive any other vaccines within four weeks prior to the COVID vaccination. On 31Mar2021, at 17:00 the patient experienced shingles diagnosis due to Pfizer shot and lowering immune system. The event resulted in emergency room/department or urgent care visit. Therapeutic measures were taken as a result of lowering immune system and included treatment with injection and prescribed prescription. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles diagnosis due to Pfizer shot lowering immune system was recovering at the time of this report. No follow-up attempts are required; information about lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1673737
Sex: F
Age:
State: OH

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 12:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 16:00, the patient experienced left arm pit pain and swelling of lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left arm pit pain and swelling of lymph nodes was resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1673738
Sex: M
Age:
State: IL

Vax Date: 04/08/2021
Onset Date: 04/11/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210409; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Weird numbness in right leg, right above knee; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Apr2021 at 15:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included sickle-cell anemia, blood clot and high blood pressure. The patient did not have any allergies to food, medications, or other products. Concomitant medications included apixaban (ELIQUIS), morphine sulfate ER (MANUFACTURER UNKNOWN) and oxycodone (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date at 03:45 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient underwent COVID-19 test (nasal swab) and the result was negative. On 11Apr2021, the patient experienced weird numbness in right leg, right above the knee. The event resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event weird numbness in right leg, right above the knee was not resolved at the time of this report No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ELIQUIS; MORPHINE SULFATE; OXYCODONE

Current Illness:

ID: 1673739
Sex: M
Age:
State: IL

Vax Date: 04/12/2021
Onset Date: 04/01/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: COVID tongue; gastrointestinal distress; intense neck pain; herpes zoster virus; re-activation of herpes zoster virus, with cold sore; re-activation of herpes zoster virus, with cold sore and red spots on face.; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 12Apr2021 at 15:45 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy, herpes zoster. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Patient did not receive any medications within two weeks of the COVID-19 vaccine. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 15Mar2021 at 16:15 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021, within two days the patient experienced intense neck pain and gastrointestinal distress. On 15Apr2021, within three the patient experienced COVID tongue. On an unknown date in Apr2021, the patient experienced re-activation of herpes zoster virus, with cold sore and red spots on face. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense neck pain and gastrointestinal distress, COVID tongue, herpes zoster virus, with cold sore and red spots on face was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness: Sulfonamide allergy

ID: 1673740
Sex: M
Age:
State: MI

Vax Date: 03/17/2021
Onset Date: 04/09/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: when lifting something or having arm in certain position a stinging sensation at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6207) via an unspecified route of administration in the left arm on 17Mar2021 at 16:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. No known allergies were reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 09Apr2021, the patient noticed when lifting something or having arm in certain position a stinging sensation at the injection site. The patient did not notice this until approximately one month after injection. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event when lifting something or having arm in certain position a stinging sensation at the injection site was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673741
Sex: F
Age:
State: OH

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: A day later around red bump appeared.; A day later around red bump appeared.; Shot was given to me in wrong location down low on fatty part of my arm and nowhere near the deltoid muscle.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 29Mar2021 at 17:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Mar2021 at 17:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. On 29Mar2021 at 17:45, the patient reported that the shot was given in wrong location down low on fatty part of the arm and nowhere near the deltoid muscle and on 30Mar2021 at 10:00, a day later around red bump appeared. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event around red bump appeared was unknown. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1673742
Sex: F
Age:
State: NJ

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210416; Test Name: Body Temperature; Result Unstructured Data: Test Result:99.7

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: 99.7 Fever; Serve migraine; Dizziness; Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease and allergy to gluten. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 12:30 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. On Friday the 16Apr2021, the patient experienced 99.7 fever (unspecified units), severe migraine, dizziness and exhaustion. The fever came on and off both Saturday 17Apr2021 and Sunday 18Apr2021, migraine and dizziness would come and go as frequently as the fever. Exhaustion lasted all three days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, severe migraine, dizziness were recovered on an unknown date in Apr2021; while that of the event exhaustion recovered on 18Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1673743
Sex: F
Age:
State: RI

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Slight numbness sensation on 1/2 of face; Slight tingling sensation on 1/2 of face; Slight numbness/tingling sensation on 1/2 of body; Slight numbness/tingling sensation on 1/2 of body; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 08Apr2021 at 16:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included an allergy to PCN (penicillin). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified prenatal vitamins, vitamin d nos (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN) and calcium (MANUFACTURER UNKNOWN); all taken for unknown indications from unknown dates and unknown if ongoing. The patient previously received oseltamivir phosphate (TAMIFLU), paracetamol; oxycodone hydrochloride (PERCOCET), azithromycin (MANUFACTURER UNKNOWN) and clindamycin (MANUFACTURER UNKNOWN) and experienced drug allergies. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccination. On 08Apr2021 at 16:30, the patient experienced slight numbness/tingling sensation on half of face/body that started immediately after receiving the shot and continued for days. The events resulted in a doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events slight numbness/tingling sensation on half of face/body was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D NOS; FISH OIL; CALCIUM

Current Illness:

ID: 1673744
Sex: M
Age:
State: FL

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 24Mar2021 at 13:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient was allergic to penicillin. The patient did not receive any medication within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021, first night after receiving the vaccine, the patient experienced ringing in both ears (tinnitus in both ears). The ringing disappeared until 05Apr2021 and came back on the evening of 05Apr2021 and was present for 15 days straight. The patient did not have any prior history of audio issues or tinnitus. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event and included treatment with Flonase, and the patient reported that it did not do anything. The clinical outcome of the event ringing in both ears was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673745
Sex: M
Age:
State: NC

Vax Date: 04/07/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Shingles (herpes zoster) infection; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 07Apr2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included GERD (gastroesophageal reflux disease) and anxiety. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included paroxetine hydrochloride (PAXIL) and lansoprazole (MANUFACTURER UNKNOWN) both taken for unspecified indications from unknown dates and unknown if ongoing. The patient previously received cefaclor (CECLOR) (antibiotic) and experienced a drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccination. On 18Apr2021 at 08:00 the patient experienced shingles (herpes zoster) infection. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event which included treatment with valaciclovir (MANUFACTURE UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles (herpes zoster) infection was resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: PAXIL [PAROXETINE HYDROCHLORIDE]; LANSOPRAZOLE

Current Illness:

ID: 1673746
Sex: F
Age:
State: SC

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Developed hot, deep red itchy skin on both arms, from mid upper arm continuously to the tops of hands. Both palms were also red and itchy. Both kneecaps were itchy and red. Both feet were itchy and red on the tops and bottoms.; Developed hot, deep red itchy skin on both arms, from mid upper arm continuously to the tops of hands. Both palms were also red and itchy. Both kneecaps were itchy and red. Both feet were itchy and red on the tops and bottoms.; Developed red, itchy blotches over face.; Also developed hot, deep red itchy skin on both arms, from mid upper arm continuously to the tops of hands.; Tenderness in right breast between armpit and right side of breast; Moderate tenderness in the injection site of right arm muscle area; Moderate pain and tenderness in right breast between armpit and right side of breast; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 12Apr2021 at 10:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) and daily vitamin (MANUFACTURER UNKNOWN); both from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 10:15, within 15 minutes of the injection, the patient developed moderate tenderness in the injection site in right arm muscle area and at the same time also developed moderate pain and tenderness in right breast between armpit and the right side of breast. The breast tenderness continued from 15 minutes post injection on 12Apr2021 until 17Apr2021. On 13Apr2021, on the morning following first injection, approximately 24 hours post injection, the patient developed red, itchy blotches over the face, also developed hot, deep red itchy skin on both the arms from mid upper arm continuously to the tops of the hands and both palms, kneecaps and feet top and bottoms were also red and itchy. The symptoms continued for approximately two and a half hours before dissipating. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tenderness in right breast between armpit and right side of breast was recovered on 17Apr2021; while that of the moderate tenderness in the injection site of right arm muscle area and moderate pain in right breast between armpit and right side of breast was recovered on an unknown date in Apr2021. The clinical outcome of the events red, itchy blotches over the face, also developed hot, deep red itchy skin on both the arms from mid upper arm continuously to the tops of the hands and both palms, kneecaps and feet top and bottoms were also red and itchy was recovered on 13Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: SPIRONOLACTONE

Current Illness:

ID: 1673747
Sex: M
Age:
State: NY

Vax Date: 04/12/2021
Onset Date: 04/15/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210419; Test Name: LUMIRADX SARS-COV-2 AG TEST; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: I lost my sense of smell three days after I had gotten my first shot, it has not returned.; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 12Apr2021 at 18:15 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to medications, food, or other products. Concomitant medications were not taken within two weeks of vaccination. The patient had received other vaccines within four weeks prior to the vaccination which included measles vaccine, mumps vaccine, rubella vaccine (MMR) on 29Mar2021 in the left arm for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient lost his sense of smell on 15Apr2021 at 12:00, three days after he had gotten his first shot, it had not returned. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 19Apr2021, the patient underwent LUMIRADX SARS-COV-2 AG test for COVID- 19 via nasal swab and the result was negative. The clinical outcome of the event lost sense of smell three days after the patient had gotten his first shot, it had not returned was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673748
Sex: F
Age:
State: WI

Vax Date: 04/09/2021
Onset Date: 04/17/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Name: COVID-19 virus test; Test Result: Positive

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Dizziness (room spinning) when laying on left side and when making quick movement up and down; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 09Apr2021 at 11:00 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included vitamins nos (VITAMINS) for an unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021, the patient experienced dizziness (room spinning) when laying on left side and when making quick movement up and down. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the event dizziness (room spinning) when laying on left side and when making quick movement up and down was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: VITAMINS NOS

Current Illness:

ID: 1673749
Sex: F
Age:
State: CO

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Experienced fatigue; Dizziness; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO153) via an unspecified route of administration in the right arm on 09Apr2021 at 10:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included nitrofurantoin (NITROFURANTOIN MONO/MAC) for unknown indication, from an unknown date and unknown if ongoing. On 09Apr2021 at 16:00, about 5 hours after shot the patient experienced fatigue, dizziness and nausea. Fatigue continued for 24 hours. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event fatigue was recovered on 10Apr2021 at 16:00 (24 hours). The clinical outcome of the events dizziness and nausea were recovered on an unknown date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds: NITROFURANTOIN MONO/MAC

Current Illness:

ID: 1673750
Sex: F
Age:
State: NY

Vax Date: 04/10/2021
Onset Date: 04/13/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Shingles; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 10Apr2021 at 11:00 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included prenatal vitamins (unspecified) from on an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 20Mar2021 at 11:00 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 13Apr2021 at 00:00, the patient was diagnosed with shingles. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the reported event and included treatment with antivirals (unspecified). The clinical outcome of the event shingles was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673751
Sex: M
Age:
State: MA

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Rash at injection site (upper right arm); Swollen glands in right armpit; Rash in armpit; Tiredness; Headache; Aches; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 17Apr2021 at 09:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included multivitamins (MANUFACTURER UNKNOWN) from an unknown date from an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 27Mar2021 at 09:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 18Apr2021 at 10:00, the patient experienced rash at injection site; upper right arm, swollen glands in right armpit with rash in armpit, tiredness, aches and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash at injection site; upper right arm, swollen glands in right armpit with rash in armpit, tiredness, aches and headache was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1673752
Sex: F
Age:
State: IA

Vax Date: 04/09/2021
Onset Date: 04/17/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Decreased sense of smell; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 09Apr2021 at 14:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to lilacs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included duloxetine (MANUFACTURER UNKNOWN) 60 mg and unspecified birth control; both for unspecified indication and from unknown date and unknown if ongoing. On 17Apr2021, the patient experienced decreased sense of smell- can only smell smoke constantly. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event decreased sense of smell- can only smell smoke constantly was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: DULOXETINE

Current Illness:

ID: 1673753
Sex: M
Age:
State: NJ

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Experienced a warm feeling that went up along neck and across the left side of face (the same side the vaccine on).; Experienced a tingly feeling that went up along neck and across the left side of face (the same side the vaccine on); This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in left arm on 19Apr2021 at 10:15 (at the age of 39-years old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 19Apr2021 at 10:45, 20 minutes after receiving the vaccination, the patient experienced a warm, tingly feeling that went up along his neck and across the left side of his face (the same side the patient's the vaccine on). After an hour the patient felt 90% better and five hours later, the patient had still felt a low sense of tingly, warm feeling along his left side of the neck and face. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctors or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of events. The clinical outcome of the events, warm and tingly feeling in neck and across the left side of face was recovering at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673754
Sex: F
Age:
State: OR

Vax Date: 03/28/2021
Onset Date: 04/01/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: hands got itchy, both the outside and the inside, in between fingers and palm; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Mar2021 at 13:15 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included Irritable Bowel Syndrome (IBS) and hay fever. The patient was allergic to penicillin. Concomitant medications included lansoprazole (MANUFACTURER UNKNOWN), citalopram (MANUFACTURER UNKNOWN) and fexofenadine (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021, 4 days after the second vaccination, the patient experienced itchy hands. She had a penicillin allergy and this event was causing much more severe itching. This was just in her hands, both the outside and the inside, in between fingers and palm itched the most. The itchiness was coming and going but was present at the time of this report. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event itchy hands both the outside and the inside, in between fingers and palm was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LANSOPRAZOLE; CITALOPRAM; FEXOFENADINE

Current Illness:

ID: 1673755
Sex: F
Age:
State: FL

Vax Date: 04/18/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Flu symptoms; Headache; Runny nose; Slight fever; Sore throat; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the arm left on 18Apr2021 at 10:30 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 20:00, the patient experienced flu symptoms, headache, runny nose, slight fever, sore throat and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events flu symptoms, headache, runny nose, slight fever, sore throat and body aches were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673756
Sex: F
Age:
State: MN

Vax Date: 04/07/2021
Onset Date: 04/12/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Rash all throughout the body; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 at 15:45 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to nuts, family history of malignant hypothermia. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN) and escitalopram (MANUFACTURER UNKNOWN) all from an unknown date for an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 17Mar2021 at 03:30 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. On 12Apr2021, the patient experienced rash all throughout the body. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash all throughout the body was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: FLUOXETINE; ESCITALOPRAM

Current Illness: Allergy to nuts (Allergy to all nuts)

ID: 1673757
Sex: F
Age:
State: VA

Vax Date: 04/03/2021
Onset Date: 04/12/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210412; Test Name: Body temperature; Result Unstructured Data: Test Result:101.3; Comments: fever (101.3 at highest); Test Date: 20210413; Test Name: Nasal Swab; Test Result: Negative; Comments: Since the vaccination, has the patient been tested for COVID-19?:Yes.

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 03Apr2021 at 15:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021, the patient experienced aches, fever (101.3 (units unspecified) at highest) and chills. The patient slept all day and night and felt better by next day afternoon. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had been tested for COVID-19. On 13Apr2021, the patient underwent lab tests and procedures that included COVID-19 test (Nasal swab) and tested negative. The clinical outcome of the events aches, fever (101.3 at highest) and chills was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673758
Sex: M
Age:
State: FL

Vax Date: 04/17/2021
Onset Date: 04/17/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Sore arm; Fever; Chills; Body ache; Joint soreness; Headache; Generally felt like a very bad flu for 2days so far; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 17Apr2021 at 10:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergies to medications, food, or other products. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), taken for an unspecified indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 12:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 at 19:00, the patient experienced sore arm, fever, chills, body aches, joint soreness, headache and generally felt like a very bad flu for 2 days, but started to get better. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as result of the events. The clinical outcome of the events sore arm, fever, chills, body aches, joint soreness, headache and generally felt like a very bad flu for 2 days were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN

Current Illness:

ID: 1673759
Sex: F
Age:
State: DC

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Terrible migraine; Taste of metal in mouth; Severe mouth pain; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 14:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications included unspecified birth control medications, spironolactone (MANUFACTURER UNKNOWN), ambrosia artemisiifolia pollen (RAGWITEK) and escitalopram oxalate (LEXAPRO); all for an unknown indication since an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 14:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 19Apr2021 at 16:30, 2.5 hours after the vaccination, the patient experienced terrible migraine, taste of metal was her in mouth. The patient looked it up and it was rare but she keeps experiencing severe mouth pain. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported adverse events. The clinical outcome of the events terrible migraine and taste of metal in mouth was unknown and the clinical outcome of the event severe mouth pain was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: SPIRONOLACTONE; RAGWITEK; LEXAPRO

Current Illness:

ID: 1673760
Sex: M
Age:
State: IL

Vax Date: 04/02/2021
Onset Date: 04/16/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the arm left on 02Apr2021 at 10:30(at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021, the patient experienced shingles to left flank. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles to left flank and included treatment with valtrex. The clinical outcome of the event shingles to left flank was not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673761
Sex: F
Age:
State: CA

Vax Date: 03/30/2021
Onset Date:
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Sore tongue; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 30Mar2021(at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included melon allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included atenolol (MANUFACTURER UNKNOWN) for unspecified indication from an unknown date. On an unknown date in 2021, the patient experienced sore tongue. The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore tongue was unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained; No further information is expected.

Other Meds: ATENOLOL

Current Illness:

ID: 1673762
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Dizziness; Soreness; Feeling unwell; foggy head; This is a spontaneous report from a non-contactable consumer, the patient. An adolescent female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date, the patient experienced dizziness, soreness, foggy head and felt unwell. The clinical outcome of the events dizziness, soreness, foggy head and felt unwell were unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1673763
Sex: F
Age:
State: CT

Vax Date: 02/10/2021
Onset Date: 02/11/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Mild headache; Low grade fever; Mild chills; Lethargic; Swollen nodes in left armpit for about 4 days; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 10Feb2021 at 17:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. The patient had known allergies to cefoxitin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), pravastatin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and celecoxib (CELEBREX); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9262) via an unspecified route of administration in the left arm on 20Jan2021 at 10:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Feb2021, 24 hours after second dose, the patient experienced mild headache, low grade fever, mild chills, lethargic which were gone the next day. On 11Feb2021, the patient had swollen nodes in left armpit for about 4 days and they too went away. The patient reported that nothing adverse since. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mild headache, low grade fever, mild chills and lethargic was recovered on 12Feb2021; while that of the swollen nodes in left armpit was recovered on 15Feb2021, after the duration of 4 days. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; PRAVASTATIN; LISINOPRIL; CELEBREX

Current Illness:

ID: 1673764
Sex: M
Age:
State:

Vax Date: 04/18/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Pain and aches in left foot; Difficultymoving toes and walking.; Pain is moderate, but quite uncomfortable; Pain is moderate, but quite uncomfortable; around 5-6 on pain scale.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 18Apr2021 at 12:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The medical history of the patient included asthma, allergy to dust, molds and seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The concomitant medications included salbutamol sulfate (ALBUTEROL SULFATE), fluticasone propionate (FLONASE) and unspecified allergy pill (MANUFACTURER UNKNOWN); all from an unknown date for an unknown indication. On 18Apr2021 at 14:30, the patient experienced pain and aches in left foot, difficulty moving toes and walking, pain was moderate, but quite uncomfortable; around 5-6 on pain scale. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain and aches in left foot, difficulty moving toes and walking and pain was moderate, but quite uncomfortable was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ALBUTEROL SULFATE; FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 1673765
Sex: F
Age:
State: CA

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Broke out in rash and hives all over body; Broke out in rash and hives all over body; Itching; Swelling; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 16:45 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication included dexlansoprazole (DEXILANT) for an unspecified indication from an unknown date and unknown if ongoing. On 16Apr2021 at 19:00, about two hours after vaccination, the patient broke out in rash and hives all over body and experienced itching and swelling. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the adverse events and included treatment with unspecified allergy medication. The clinical outcome of the events broke out in rash and hives all over body, itching and swelling was recovered on an unknown date in Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: DEXILANT

Current Illness:

ID: 1673766
Sex: F
Age:
State: NJ

Vax Date: 03/01/2021
Onset Date: 04/01/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in left arm in Mar2021 (at the age of 54-years old) as a single dose for COVID-19 immunisation. The patient's medical history included rheumatoid arthritis, shingles, herbal allergy (chamomile), ragweed allergy and fruit allergy (melon). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. In Apr2021, a week after receiving the second dose, the patient begun to experience neuralgic pains similar to those which she had experienced when she had shingles in the past year. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event, neuralgic pains was recovering at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1673767
Sex: F
Age:
State: NC

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Swollen Lymph Node - left clavicle; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 17Apr2021 at 11:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food, or other products. Concomitant medications included estrogen (MANUFACTURER UNKNOWN), progesterone (MANUFACTURER UNKNOWN), valaciclovir hydrochloride (VALTREX) and melatonin (MANUFACTURER UNKNOWN); all from unknown dates, for unknown indications and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021, the patient experienced swollen lymph node in the left clavicle. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event swollen lymph node in the left clavicle was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ESTROGEN NOS; PROGESTERONE; VALTREX; MELATONIN

Current Illness:

ID: 1673768
Sex: M
Age:
State: OH

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Hives 2 hours later; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 19Apr2021 at 13:45 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 15:30, the patient experienced hives 2 hours later. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of adverse events and included treatment with ZYRTEC and prednisone. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event hives 2 hours later was recovered with sequelae on 19Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1673769
Sex: F
Age:
State: IL

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: During the night after 2nd dose felt flu like symptoms. The next day could not get out of bed. This lasted for another 24 hours.; During the night after 2nd dose felt flu like symptoms. The next day could not get out of bed. This lasted for another 24 hours.; Made me very weak and with a headache for the next 24 hours; Made me very weak and with a headache for the next 24 hours; This is a spontaneous report from a non-contactable consumer, the patient. A 76-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 16Apr2021 at 14:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. The patient previously took estrogens conjugated; medroxyprogesterone acetate (PREMPRO) on unknown date for unknown indication and experienced drug allergy. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 26Mar2021 at 14:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 at 02:30, during the night after second dose the patient felt flu like symptoms. The next day on 17Apr2021, she could not get out of bed. This lasted for another 24 hours. It had made her very weak and with a headache for the next 24 hours. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events during the night after second dose felt flu like symptoms, the next day could not get out of bed, this lasted for another 24 hours, made her very weak and with a headache for the next 24 hours was resolved on 18Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1673770
Sex: F
Age:
State:

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Swollen tongue; Sore throat; Swollen lymph node near armpit under left arm; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 17Apr2021 at 09:15 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 09:15 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. On 18Apr2021 at 11:00 the patient experienced swollen lymph node near armpit under left arm, swollen tongue and sore throat as well. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lymph node near armpit under left arm, swollen tongue and sore throat were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673771
Sex: M
Age:
State:

Vax Date: 04/12/2021
Onset Date: 04/01/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data: Test Date: 20210413; Test Name: body temperature; Result Unstructured Data: Test Result:99.6 Units:[degF]; Comments: Low grade fever - 99.6 F

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: This is a spontaneous report from a non-contactable consumer. A 44-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 12Apr2021 at 11:30 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history and Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 23Mar2021 at 09:00 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 03.00, the patient experienced low grade fever ~99.6 Fahrenheit, muscle aches, fatigue and sore arm for approximately 36hours; Injection site redness and itching starting about 2-3 days post injection. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 13Apr2021 patient checked his body temperature and it was 99.6 Fahrenheit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events low grade fever ~99.6 Fahrenheit, muscle aches, fatigue and sore arm were recovered on unknown date in Apr2021. The clinical outcome of the event injection site redness and itching were recovered on 18Apr2021 (lasted until18Apr2021). No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1673772
Sex: F
Age:
State: TX

Vax Date: 04/01/2021
Onset Date: 04/04/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Fever; joint aches; vomiting; tiredness; headache; muscle pain; nausea; feeling unwell; swollen lymph nodes; Sick for 2 days; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 00:00 (at the age of 76-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine, liothyronine (NP THYROID). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Mar2021 at 00:00 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021, the patient experienced fever, joint aches, vomiting, tiredness, headache, muscle pain, nausea, feeling unwell, swollen lymph nodes and sick for 2 days. Took 2 weeks to recover. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome for the events fever, joint ache, vomiting, tiredness, headache, muscle pain, nausea, feeling unwell, swollen lymph nodes were recovering. The clinical outcome of the event sick was recovered on 06Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: NP THYROID

Current Illness:

ID: 1673773
Sex: M
Age:
State: GA

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 02Apr2021 at 18:30 (at the age of 60-old-years) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included levothyroxine sodium (MANUFACTURER UNKNOWN) and atorvastatin calcium (MANUFACTURER UNKNOWN); both for unspecified indication and start date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 12Mar2021 at 19:30 (at the age of 60-old-years) as a single dose for COVID-19 immunisation. The patient did not have any allergies to any medications, food, or other products. On 02Apr2021, the patient experienced tinnitus. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE SODIUM; ATORVASTATIN

Current Illness:

ID: 1673774
Sex: F
Age:
State: PA

Vax Date: 04/18/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Rash around injection site; Headache; Hot flashes; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Apr2021 at 10:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included cyclic vomiting syndrome and hepatitis c with 0 viral load. Concomitant medications included naloxone hydrochloride, buprenorphine hydrochloride (SUBOXONE) for unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 11:45 the patient experienced rash around injection site, headache and hot flashes. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the events rash around injection site, headache and hot flashes were resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: SUBOXONE

Current Illness:

ID: 1673775
Sex: F
Age:
State:

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Vaccine side swollen lymph nodes near collar bone; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 17Apr2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Other medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 27Mar2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021, the patient experienced vaccine side swollen lymph nodes near collar bone. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vaccine side swollen lymph nodes near collar bone was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected

Other Meds:

Current Illness:

ID: 1673776
Sex: F
Age:
State: KS

Vax Date: 04/12/2021
Onset Date: 04/16/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: tested for antibodies to varicella/shingles; Result Unstructured Data: Test Result:Highy elevated antibodies probably being shingles

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Got small rash on left side of abdomen; Was tested for antibodies to varicella/shingles.Received call 4/19/21 for highy elevated antibodies probably being shingles.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 12Apr2021 at 11:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome and varicella. Concomitant medications included norethisterone (ERRIN) and ibuprofen (MANUFACTURER UNKNOWN). The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm left on 22Mar2021 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 08:00, the patient got small rash on left side of abdomen. Went to the clinic on 18Apr2021 for advice on what to use on it. The patient had a history of varicella as a child but no known stress or unusual circumstances that would trigger a reaction and no history of shingles previously. The patient was tested for antibodies to varicella/shingles and was diagnosed with highly elevated antibodies probably being shingles on 19Apr2021. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of small rash on left side of abdomen and highly elevated antibodies probably being shingles which included treatment with Medrol (Pak). The clinical outcome of the event small rash on left side of abdomen and highly elevated antibodies probably being shingles was resolving at the time of this report No follow-up attempts are needed. No further information is expected.

Other Meds: NORETHINDRONE [NORETHISTERONE]; IBUPROFEN

Current Illness:

ID: 1673777
Sex: F
Age:
State: MI

Vax Date: 04/17/2021
Onset Date: 04/19/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Rash similar to what patient got after viralinfection started on Monday 4/19; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 17Apr2021 at 15:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included eczema, penicillin allergy and sulfur drug sensitivity. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously took BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 27Mar2021 at 08:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 21:00, the patient experienced rash similar to what the patient got after viral infection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash similar to what the patient got after viral infection was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1673778
Sex: F
Age:
State: CA

Vax Date: 04/18/2021
Onset Date: 04/18/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Swelling of lips within one minute.; Red blotches on face and neck; tingling in tongue and palate; This is a spontaneous report from a contactable physician, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Apr2021 at 15:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, hypertension (HTN), lipids increased (reported as elevated lipids). The patient previously had shellfish and experienced shellfish allergy. The patient also had tree nuts previously and experienced allergy to nuts. The patient previously took fluvastatin sodium (LESCOL) and levofloxacin(LEVAQUIN), both on unknown date for unknown indication and experienced drug allergy. Concomitant medications taken within two weeks of vaccination included amlodipine besilate (NORVASC), formoterol fumarate, mometasone furoate (DULERA), montelukast sodium (SINGULAIR), fexofenadine hydrochloride (ALLEGRA) and vitamin d nos (MANUFACTURER UNKNOWN); all from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced swelling of lips within one minute on 18Apr2021 at 15:45. On 18Apr2021 at 15:45 the patient also experienced red blotches on face and neck. She also had tingling in tongue and palate. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of swelling of lips within one minute, red blotches on face and neck, tingling in tongue and palate and included treatment at site, Benadryl 50milligram, next at emergency room, Solumedrol/Ben. The clinical outcome of the events swelling of lips within one minute, red blotches on face and neck, tingling in tongue and palate was resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: NORVASC; DULERA; SINGULAIR; ALLEGRA; VITAMIN D NOS

Current Illness:

ID: 1673779
Sex: F
Age:
State: TX

Vax Date: 04/03/2021
Onset Date: 04/07/2021
Rec V Date: 09/04/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Tinnitus in left ear; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 03Apr2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included lamotrigine (MANUFACTURER UNKNOWN) taken for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccination. On 07Apr2021 at 20:45, the patient experienced tinnitus in left ear. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus in left ear was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LAMOTRIGINE.

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am